BLEEDnFIRE Therapeutics
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$170,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BLEEDnFIRE Therapeutics is a biotechnology company developing first-in-class RNA-based therapies for rare bleeding disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BLEEDnFIRE Therapeutics Comparables
Compare BLEEDnFIRE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 72% | |
| Hemab Therapeutics | 70% | |
| Sanofi | 69% |
BLEEDnFIRE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Grant | Nov 29, 2024 |
BLEEDnFIRE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Kickfund | Grant |
| Innosuisse | Grant |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Received funding from Kickfund, Gebert Rüf Stiftung, Innosuisse, and Venture Kick.
- Nov 29, 2024
$170K grant received from Venture Kick.
BLEEDnFIRE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BLEEDnFIRE Therapeutics's valuation, stock price, and market status.
Is BLEEDnFIRE Therapeutics a public or private company?
BLEEDnFIRE Therapeutics is a private company.
What is the current stock price of BLEEDnFIRE Therapeutics?
BLEEDnFIRE Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is BLEEDnFIRE Therapeutics worth (valuation)?
Valuation information for BLEEDnFIRE Therapeutics is not publicly available.
Can I buy BLEEDnFIRE Therapeutics stock?
BLEEDnFIRE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BLEEDnFIRE Therapeutics's last funding round?
BLEEDnFIRE Therapeutics's most recent funding round was Grant on May 27, 2026.
Who are the main investors in BLEEDnFIRE Therapeutics?
Key investors in BLEEDnFIRE Therapeutics include Gebert Rüf Stiftung, Kickfund, Innosuisse, Venture Kick.
Will BLEEDnFIRE Therapeutics IPO soon?
No public IPO plans have been announced for BLEEDnFIRE Therapeutics.
How can I track BLEEDnFIRE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BLEEDnFIRE Therapeutics's secondary market activity and sign up for updates.